FARALLON CAPITAL MANAGEMENT, L.L.C.

Fundamental diversified ★Signal CIK 909661
League rank
#719
in Fundamental diversified · #6630 overall
Long book
$16.79B
Q1 2026
Positions
168
Top-10 weight
51%
concentration
Last quarter
-6.0%
SPY -4.4%
Turnover
37%
of book per quarter

Strategy in plain words

auto-generated from filings

FARALLON CAPITAL MANAGEMENT, L.L.C. is a diversified fundamental manager, running a $16.79B US long book across 168 positions.

The portfolio is concentrated: the top 10 names carry 51% of the portfolio. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: ELECTRONIC ARTS INC, REVOLUTION MEDICINES INC, AMAZON.COM INC, MICROSOFT CORP, AON PLC-CLASS A.

Over the last 8 quarters its long book ran on average 0.4pp per quarter behind the S&P 500, beating the index in 3 of 8 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q1 2024
+0.5%
Q2 2024
+11.4%
Q3 2024
+0.5%
Q4 2024
-4.0%
Q1 2025
+8.4%
Q2 2025
+4.0%
Q3 2025
+7.9%
Q4 2025
-6.0%

Sector allocation

Healthcare
43%
Technology
23%
Financials
13%
Consumer discretionary
9%
Services media
4%
Industrials
3%
Other
3%
Materials
3%

Long book by quarter

$16.65B
Q1 2024
$16.60B
Q2 2024
$18.04B
Q3 2024
$18.92B
Q4 2024
$18.55B
Q1 2025
$21.89B
Q2 2025
$17.70B
Q3 2025
$19.24B
Q4 2025
$16.79B
Q1 2026

What does FARALLON CAPITAL own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
EA ELECTRONIC ARTS INCTechnology7.5M$1.52B9.1%+48.4%
RVMD REVOLUTION MEDICINES INCHealthcare13.6M$1.32B7.9%-6.7%
AMZN AMAZON.COM INCConsumer discretionary4.2M$878.6M5.2%-6.3%
MSFT MICROSOFT CORPTechnology2.3M$868.0M5.2%+5.9%
AON AON PLC-CLASS AFinancials2.5M$811.0M4.8%-5.7%
BBIO BRIDGEBIO PHARMA INCHealthcare9.4M$695.5M4.1%+4.1%
PTGX PROTAGONIST THERAPEUTICS INCHealthcare6.3M$669.2M4.0%+3.3%
NTRA NATERA INCHealthcare3.2M$641.4M3.8%-18.1%
EXEL EXELIXIS INCHealthcare13.1M$562.3M3.3%-16.5%
AVGO BROADCOM INCTechnology1.8M$550.8M3.3%+99.4%
UNH UNITEDHEALTH GROUP INCFinancials1.8M$492.9M2.9%+13.9%
SNPS SYNOPSYS INCTechnology1.2M$481.0M2.9%+21.4%
BSX BOSTON SCIENTIFIC CORPHealthcare7.5M$468.8M2.8%+0.4%
TMO THERMO FISHER SCIENTIFIC INCOther881.5K$433.3M2.6%+38.7%
KKR KKR & CO INCFinancials4.7M$432.1M2.6%+131.5%
LNTH LANTHEUS HOLDINGS INCMaterials5.6M$423.5M2.5%+2.9%
WAB WABTEC CORPIndustrials1.6M$402.2M2.4%-35.0%
SCHW SCHWAB (CHARLES) CORPFinancials4.0M$371.8M2.2%+18.4%
LQDA LIQUIDIA CORPHealthcare8.7M$326.7M1.9%Held
CRNX CRINETICS PHARMACEUTICALS INHealthcare8.3M$302.8M1.8%+20.3%
GOOG ALPHABET INC-CL CTechnology996.2K$285.8M1.7%+26.6%
ROIV ROIVANT SCIENCES LTDHealthcare9.7M$268.0M1.6%+26048.6%
V VISA INC-CLASS A SHARESServices media840.7K$254.1M1.5%+20.8%
ARMK ARAMARKConsumer discretionary6.1M$248.7M1.5%-34.4%
BEAM BEAM THERAPEUTICS INCHealthcare10.1M$241.5M1.4%+0.7%
DIS WALT DISNEY CO/THEServices media2.4M$231.5M1.4%-41.8%
MA MASTERCARD INC - AServices media435.1K$217.4M1.3%+152.0%
MCK MCKESSON CORPConsumer discretionary234.3K$202.8M1.2%-21.6%
AGIO AGIOS PHARMACEUTICALS INCHealthcare5.7M$192.3M1.1%+10.2%
TNGX TANGO THERAPEUTICS INCHealthcare9.1M$190.3M1.1%-30.3%
GRAL GRAIL INCHealthcare3.3M$168.2M1.0%+38.9%
TYRA TYRA BIOSCIENCES INCHealthcare3.6M$137.1M0.8%+73.3%
THC TENET HEALTHCARE CORPHealthcare452.2K$85.3M0.5%+21.5%
CAH CARDINAL HEALTH INCConsumer discretionary368.0K$77.8M0.5%-36.1%
PCVX VAXCYTE INCHealthcare1.3M$73.3M0.4%+25120.0%
DNTH DIANTHUS THERAPEUTICS INCHealthcare836.0K$70.2M0.4%New
BTSG BRIGHTSPRING HEALTH SERVICESHealthcare1.6M$68.9M0.4%+7250.0%
TWST TWIST BIOSCIENCE CORPHealthcare1.4M$67.8M0.4%+18562.1%
CGON CG ONCOLOGY INCHealthcare674.0K$45.6M0.3%+8325.0%
AZN ASTRAZENECA PLCHealthcare226.5K$44.7M0.3%New
MRK MERCK & CO. INC.Healthcare361.0K$43.4M0.3%New
ACHC ACADIA HEALTHCARE CO INCHealthcare1.7M$40.6M0.2%New
IMVT IMMUNOVANT INCHealthcare1.5M$38.4M0.2%+12783.3%
ENTA ENANTA PHARMACEUTICALS INCHealthcare2.9M$36.3M0.2%+3.6%
JNJ JOHNSON & JOHNSONHealthcare148.0K$36.2M0.2%New
BBNX BETA BIONICS INCHealthcare3.6M$36.2M0.2%-16.4%
ASMB ASSEMBLY BIOSCIENCES INCHealthcare1.2M$34.1M0.2%Held
PCSC PERCEPTIVE CAPITAL SOLUTIONSHealthcare2.3M$24.7M0.1%Held
RPRX ROYALTY PHARMA PLC- CL AHealthcare493.0K$23.6M0.1%New
NERV MINERVA NEUROSCIENCES INCHealthcare2.4M$14.2M0.1%Held

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HR/ANEW HOLDINGSAug 14, 20261$1.52B canonicalSEC ↗
Q1 202613F-HRMay 15, 2026172$17.54Bconfidential canonicalSEC ↗
Q4 202513F-HR/ANEW HOLDINGSAug 14, 20261$1.03B canonicalSEC ↗
Q4 202513F-HR/ANEW HOLDINGSMay 15, 20262$883.7M canonicalSEC ↗
Q4 202513F-HRFeb 17, 2026151$20.72Bconfidential canonicalSEC ↗
Q3 202513F-HR/ARESTATEMENTFeb 17, 2026144$24.43B canonicalSEC ↗
Q3 202513F-HRNov 14, 2025144$24.43Bconfidential SEC ↗
Q2 202513F-HR/ANEW HOLDINGSFeb 17, 20261$140.2M canonicalSEC ↗
Q2 202513F-HR/ANEW HOLDINGSNov 14, 20253$482.8M canonicalSEC ↗
Q2 202513F-HRAug 14, 2025141$23.18Bconfidential canonicalSEC ↗
Q1 202513F-HR/ANEW HOLDINGSFeb 17, 20261$273.9M canonicalSEC ↗
Q1 202513F-HR/ANEW HOLDINGSNov 14, 20253$416.4M canonicalSEC ↗
Q1 202513F-HR/ANEW HOLDINGSAug 14, 20257$2.23B canonicalSEC ↗
Q1 202513F-HRMay 15, 2025135$17.94Bconfidential canonicalSEC ↗
Q4 202413F-HR/ANEW HOLDINGSFeb 17, 20261$84.9M canonicalSEC ↗
Q4 202413F-HR/ANEW HOLDINGSNov 14, 20252$349.2M canonicalSEC ↗
Q4 202413F-HR/ANEW HOLDINGSAug 14, 20256$2.31B canonicalSEC ↗
Q4 202413F-HR/ANEW HOLDINGSMay 15, 20254$333.0M canonicalSEC ↗
Q4 202413F-HRFeb 14, 2025138$19.72B canonicalSEC ↗
Q3 202413F-HR/ANEW HOLDINGSNov 14, 20251$144.8M canonicalSEC ↗
Q3 202413F-HR/ANEW HOLDINGSAug 14, 20256$1.45B canonicalSEC ↗
Q3 202413F-HR/ANEW HOLDINGSMay 15, 20253$215.9M canonicalSEC ↗
Q3 202413F-HR/ANEW HOLDINGSFeb 14, 20252$544.4M canonicalSEC ↗
Q3 202413F-HRNov 14, 2024153$20.44Bconfidential canonicalSEC ↗